Dispensable role of CCL28 in Kras-mutated non-small cell lung cancer mouse models

被引：5
|
作者：
Lin, Dandan [1 ]
Zhang, Mengxin [2 ,3 ]
Guo, Hao [2 ,3 ]
Deng, Yu [4 ]
Zhong, Bo [2 ,3 ]
Liao, Fei [5 ]
Xu, Zhigao [6 ]
机构：
[1] Wuhan Univ, Renmin Hosp, Canc Ctr, Wuhan 430060, Peoples R China
[2] Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Gastrointestinal Surg, Dept Immunol,Med Res Inst, Wuhan 430071, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Thorac Surg, Tongji Hosp, Wuhan 430030, Peoples R China
[5] Wuhan Univ, Renmin Hosp, Gastroenterol Dept, Wuhan 430060, Peoples R China
[6] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan 430071, Peoples R China
来源：
ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 2020年 / 52卷 / 06期
关键词：
CHEMOKINE; BIOLOGY;
D O I：
10.1093/abbs/gmaa032
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：691 / 694
页数：4
相关论文
共 50 条
  • [1] Realities of KRAS-mutated non-small cell lung cancer
    Min, Young Joo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 442 - 442
  • [2] Management of KRAS-Mutated Non-Small Cell Lung Cancer
    Malhotra, Jyoti
    Nguyen, Danny
    Tan, Tingting
    Semeniuk, George B.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (02) : 67 - 75
  • [3] Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
    Sousa, Catarina C.
    Pinto, Josue
    Martins, Natalia
    Teixeira, Sofia
    Magalhaes, Adriana
    Fernandes, Gabriela
    Hespanhol, Venceslau
    Queiroga, Henrique
    Bastos, Helder Novais
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Peravali, M.
    Gomes-Lima, C.
    Tefera, E.
    Baker, M.
    Sherchan, M.
    Farid, S.
    Burman, K.
    Constantinescu, F.
    Veytsman, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S300 - S301
  • [5] Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk
    Wing, Sam E.
    Jankowska, Marta M.
    Zou, Xiaoke
    Sosa, Ernesto
    Yang, Jiue-An
    Benmarhnia, Tarik
    Neuhausen, Susan L.
    Nelson, Rebecca
    Salgia, Ravi
    Gray, Stacy W.
    Erhunmwunsee, Loretta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 5231 - 5240
  • [6] Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk
    Sam E. Wing
    Marta M. Jankowska
    Xiaoke Zou
    Ernesto Sosa
    Jiue-An Yang
    Tarik Benmarhnia
    Susan L. Neuhausen
    Rebecca Nelson
    Ravi Salgia
    Stacy W. Gray
    Loretta Erhunmwunsee
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5231 - 5240
  • [7] Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics
    Zhang, Yuda
    Zeng, Fanxu
    Peng, Shixuan
    Chen, Yangqian
    Jiang, Wenjuan
    Wang, Zhan
    Deng, Li
    Huang, Zhe
    Qin, Haoyue
    Yan, Huan
    Zhang, Xing
    Zhang, Lin
    Yang, Nong
    Gong, Qian
    Zeng, Liang
    Zhang, Yongchang
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (09) : 743 - 751
  • [8] A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non-Small Cell Lung Cancer
    Vasan, Neil
    Boyer, Julie L.
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 3921 - 3930
  • [9] Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
    O'Sullivan, Eabha
    Keogh, Anna
    Henderson, Brian
    Finn, Stephen P.
    Gray, Steven G.
    Gately, Kathy
    CANCERS, 2023, 15 (06)
  • [10] Contribution of smoking habit to the prognosis of stage I KRAS-mutated non-small cell lung cancer
    Kuroda, Hiroaki
    Yoshida, Tatsuya
    Arimura, Takaaki
    Mizuno, Tetsuya
    Sakakura, Noriaki
    Yatabe, Yasushi
    Sakao, Yukinori
    CANCER BIOMARKERS, 2018, 23 (03) : 419 - 426
12345